Arch Venture Fund XII reported a 5.3% stake in Parabilis Medicines PBLS · 6,412,780 sh · passive holder

Trade details

Type: 5% stake report
Report: 13G passive
Stake: 5.3%
Last report: First report
Shares held: 6,412,780 sh
Class: Common Stock, $0.0001 par value
Stock: Parabilis Medicines PBLS
Holder: Arch Venture Fund XII
Event date: 26/06/30
Filed: 26/08/14

First 5%+ report · 5.3% stake

Parabilis Medicines trades, last 26 weeks

What else happened in Parabilis Medicines around then

Filed or reported within 30 days of the trade day · 05/31~07/30

Arch Venture Fund XII's other 5% stake reports

Arch Venture Fund XII
5% stakeSeaport Therapeutics
5% stake
Seaport Therapeutics
SPTX
11.9% stake
6,294,951 sh
11.9% stake
Filed 05/06
Arch Venture Fund XII
5% stakeNeumora Therapeutics
5% stake
Neumora Therapeutics
NMRA
18.7% stake
33,965,419 sh
18.7% stake
Filed 04/01
Arch Venture Fund XII
5% stakeNeumora Therapeutics
5% stake
Neumora Therapeutics
NMRA
20.7% stake
33,958,967 sh
20.7% stake
Filed 25/10/29
Arch Venture Fund XII
5% stakePrime Medicine
5% stake
Prime Medicine
PRME
10.4% stake
18,587,036 sh
10.4% stake
Filed 25/08/11